Stoke Therapeutics, Inc. has been removed from NASDAQ Biotechnology Index .
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.02 USD | -3.14% | +7.69% | +130.32% |
Apr. 17 | Stoke Therapeutics Appoints Jason Hoitt as Chief Commercial Officer | CI |
Mar. 28 | Sector Update: Health Care Stocks Advance Premarket Thursday | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+130.32% | 647M | |
+2.21% | 42.75B | |
+47.70% | 41.61B | |
+11.32% | 41.34B | |
-12.36% | 26.59B | |
+7.90% | 25.49B | |
-23.72% | 18.12B | |
+29.58% | 12.24B | |
-1.99% | 11.76B | |
+7.88% | 11B |
- Stock Market
- Equities
- STOK Stock
- News Stoke Therapeutics, Inc.
- Stoke Therapeutics, Inc.(NasdaqGS: STOK) dropped from NASDAQ Biotechnology Index